Microalbuminuria and Pulse Pressure in Hypertensive and Atherosclerotic Men

Hypertension

Volumn 35, Issue 1, 2000, Pages 48-

  Pedrinelli, Roberto ^a   Dell’Omo, Giulia ^a   Penno, Giuseppe ^a   Bandinelli, Simona ^a   Bertini, Alessio ^a   Di Bello, Vitantonio ^a   Mariani, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Albuminuria; Hypertension, essential; Mass, ventricular; Pressure; Vascular diseases

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAM; FEMALE; HEART FUNCTION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; PULSE PRESSURE; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS;

ADULT; AGED; ALBUMINURIA; ARTERIOSCLEROSIS; BLOOD PRESSURE; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0033954455     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.35.1.48     Document Type: Article

References (40)

1. Jensen JS, Feldt-Rasmussen B, Borch-Johnsen K, Clausen P, Appleyard M, Jensen G. Microalbuminuria and its relation to cardiovascular disease and risk factors: a population-based study of 1254 hypertensive individuals. J Hum Hypertens. 1997; 11:727-732.
2. Bigazzi R, Bianchi S, Baldari D, Campese VM. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens. 1998; 16:1325-1333.
3. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non diabetic subjects. Lancet. 1988; ii:530-533.
4. Kuusisto J, Mykkanen L, Pyorala K, Laakso M. Hyperinsulinemic microalbuminuria: a new risk indicator for coronary heart disease. Circulation. 1995; 91:831-837.
5. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE. Microalbuminuria as a predictor of increased mortality in elderly people. BMJ. 1990; 300:297-300.
6. Jensen JS, Feldt-Rasmussen B, Borch-Johnsen K, Jensen G. Urinary albumin excretion in a population based sample of 1011 middle aged non diabetic subjects: the Copenhagen City Heart Study Group. Scand J Clin Lab Invest. 1993; 53:867-872.
7. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart study. N Engl J Med. 1990; 322:1561-1566.
8. Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk of sudden death. J Am Coll Cardiol. 1998; 32:1454-1459.
9. Smulyan H, Safar ME. Systolic blood pressure revisited. J Am Coll Cardiol. 1997; 29:1407-1413.
10. Glasser SP, Arnett DK, McVeigh GE, Finkelstein SM, Bank AJ, Morgan DJ, Cohn JN. Vascular compliance and cardiovascular disease: a risk factor or a marker? Am J Hypertens. 1997; 10:1175-1189.
11. Benetos A, Laurent S, Asmar RG, Lacolley P. Large artery stiffness in hypertension. J Hypertens. 1997; 15(suppl 2):S89-S97.
12. Anderson TJ, Gerhard MD, Meredith IT, Charbonneau F, Delagrange D, Creager MA, Selwin AP, Ganz P. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol. 1995; 75:71b-74b.
13. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 1989; 32:219-226.
14. Criqui MH, Denenberg JO. The generalized nature of atherosclerosis: how peripheral arterial disease may predict adverse events from coronary artery disease. Vasc Med. 1998; 3:241-245.
15. Safar ME, Toto-Moukomo JJ, Bouthier JA, Asmar RA, Laurent SM. Increased pulse pressure in patients with arteriosclerosis obliterans of the lower limbs. Arteriosclerosis. 1987; 7:232-237.
16. Fabsitz RR, Sidaway AN, Go O, Lee ET, Weity TK, Devereux RB, Howard BV. Prevalence of peripheral arterial disease and associated risk factors in American Indians. Am J Epidemiol. 1999; 149:330-338.
17. Pedrinelli R, Penno G, Dell’Omo G, Bandinelli S, Giorgi D, Di Bello V, Nannipieri M, Navalesi R, Mariani M. Transvascular and urinary leakage of albumin in atherosclerotic and hypertensive men. Hypertension. 1998; 32:312-318.
18. Jager A, Kostense PJ, Ruhe HG, Heine RJ, Nijpels G, Dekker JM, Bouter LM, Stehouwer CDA. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol. 1999; 19:617-624.
19. Franklin SS, Gustin W, Wong ND, Larson MGF, Weber MA, Kannel WB, Levy D. Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study. Circulation. 1997; 96:308-315.
20. Campese VM, Bianchi S, Bigazzi R. Association between hyperlipidemia and microalbuminuria in essential hypertension. Kidney Int. 1999; 56(suppl 71):S10-S13.
21. Pedrinelli R, Giampietro O, Carmassi O, Melillo E, Dell’Omo G, Catapano G, Matteucci E, Talarico L, Morale M, De Negri F, Di Bello V. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet. 1994; 344:14-18.
22. Mimran A, Ribstein J, Du Cailar G, Halimi JM. Albuminuria in normals and essential hypertension. J Diabetes Complications. 1994; 8:150-156.
23. Clausen P, Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Ambulatory blood pressure and urinary albumin excretion in clinically healthy subjects. Hypertension. 1998; 32:71-77.
24. Kasiske BL, Rith-Najarian S, Casper ML, Croft JB. American Indian heritage and risk factors for renal injury. Kidney Int. 1998; 54:1305-1310.
25. Safar ME, St Laurent S, Safavian AL, Pannier BM, London GM. Pulse pressure in sustained essential hypertension: a haemodynamic study. J Hypertens. 1987; 5:213-218.
26. Cirillo M, Senigalliesi L, Laurenzi M, Alfieri R, Stamler J, Stamler R, Panarelli W, De Santo NG. Microalbuminuria in non diabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels and smoking: the Gubbio population study. Arch Int Med. 1998; 158:1933-1939.
27. Goetz FC, Jacobs DR, Chavers B, Roel J, Yelle M, Sprafka JM. Risk factors for kidney damage in the adult population of Wadena, Minnesota: a prospective study. Am J Epidemiol. 1997; 145:91-102.
28. Agewall S, Fagerberg B. Risk factors that predict development of microalbuminuria in treated hypertensive men: the Risk Intervention Study Group. Angiology. 1996; 47:963-972.
29. James MA, Watt PAC, Potter JF, Thurston H, Swales JD. Pulse pressure and resistance artery structure in the elderly. Hypertension. 1995; 26:301-306.
30. Fogo A, Breyer JA, Smith MC, Cleveland WH, Agodoa L, Kirk KA, Glassock R. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) trial. Kidney Int. 1997; 51:244-252.
31. Blacher J, Asmar R, Saliha D, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension. 1999; 33:1111-1117.
32. Whelton PK, Perneger TV, He J, Klag MJ. The role of blood pressure as a risk factor for renal disease: a review of the epidemiologic evidence. J Hum Hypertens. 1996; 10:683-689.
33. London GM, Drueke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int. 1997; 51:1678-1995.
34. Benetos A, Rudnichi A, Safar M, Guize L. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension. 1998; 32:560-564.
35. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Pede S, Porcellati C. Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Hypertension. 1998; 32:983-988.
36. Hoogeveen EK, Kostense PJ, Jager A, Heine RJ, Jakobs C, Bouter LM, Donker AJM, Stehouwer CDA. Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study. Kidney Int. 1998; 54:203-209.
37. Pedrinelli R, Di Bello VA, Catapano G, Talarico L, Materazzi F, Santoro G, Giusti C, Mosca F, Melillo E, Ferrari M. Microalbuminuria is a marker of left ventricular hypertrophy but not hyperinsulinemia in non diabetic atherosclerotic patients. Arterioscler Thromb. 1993; 13:900-906.
38. Gatzka CD, Reid CM, Lux A, Dart AM, Jennings G. Left ventricular mass and microalbuminuria: relation to ambulatory blood pressure: Hypertension Diagnostic Service Investigators. Clin Exp Pharmacol Physiol. 1999; 26:514-516.
39. Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y, Kangawa K, Matsuo H, Omae T, Matsuoka H. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension. 1996; 28:22-30.
40. Mc Murray J, Seidelin PH, Howey JE, Balfour DJ, Struthers AD. The effect of atrial natriuretic factor on urinary albumin and beta 2-microglobulin excretion in man. J Hypertens. 1988; 6:783-786.